Filing Flows › Iradimed (IRMD) › Q2 2026
Iradimed (IRMD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 31, 2026
Iradimed (IRMD) reported revenue of $20.5M for the second quarter 2026 (Q2 2026), +0.3% from a year earlier and -7% from the quarter before. Operating margin was 31.2%, net earnings $5.2M (25.5% of revenue).
Iradimed, Q2 2026: revenue $20.5M (+0.3% year over year), operating margin 31.2%, net earnings $5.2M, operating cash flow $5.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.5M | -7% | +0.3% |
| Gross profit | $15.2M | -10% | -5% |
| Operating profit | $6.4M | -12% | -6% |
| Net earnings | $5.2M | -10% | -10% |
| Operating cash flow | $5.9M | -28% | -23% |
| Free cash flow | $5.8M | -27% | +13% |
What changed
Revenue was $20.5M in Q2 2026, roughly flat year over year and down 7% from the previous quarter. MRI Compatible Patient Vital Signs Monitoring Systems was the largest line at 33% of revenue. MRI Compatible Patient Vital Signs Monitoring Systems added $721K year over year (up 12%), 1265% of the total change. MRI Compatible IV Infusion Pumps declined 21%.
Gross margin was 74.1%, down 4.1 points from Q2 2025. Operating profit was $6.4M, a 31.2% margin (down 2.0 points year over year). Operating profit fell $397K even though revenue rose $57K versus Q2 2025, so costs grew faster than sales. Operating expenses fell 4% while revenue was flat. Net earnings were $5.2M, down 10% year over year. The effective tax rate was 24.2%.
Operating cash flow was $5.9M (down 23% year over year), 114% of net earnings. Non-cash charges added back $410K of depreciation and amortization and $807K of share-based compensation. Working capital and other items used $495K. Capital expenditures of $185K left free cash flow of $5.8M.
Questions
What was Iradimed's revenue in the second quarter 2026?
Iradimed (IRMD) reported revenue of $20.5M for the second quarter 2026 (Q2 2026), +0.3% from a year earlier and -7% from the quarter before.
Was Iradimed profitable in the second quarter 2026?
Operating profit was $6.4M (31.2% of revenue) and net earnings $5.2M.
Source: Iradimed 10-Q on SEC EDGAR.